Skip to content

Clinical trials

Phase 1 Leukemia, Myeloid, Acute trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1 Country / region: Israel Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Active, not recruiting1
Completed1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Novartis Pharmaceuticals2
Eli Lilly and Company1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute8
Myelodysplastic Syndromes3
Neoplasms3
Leukemia, Myelomonocytic, Chronic2
Lymphoma, Non-Hodgkin2
Carcinoma, Non-Small-Cell Lung1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1
Multiple Myeloma1
Myeloproliferative Disorders1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.